Cell cycle phase perturbations and apoptosis in tumour cells induced by aplidine.
about
Adding pharmacogenomics to the development of new marine-derived anticancer agentsMarine Natural Products as Inhibitors of Hypoxic Signaling in Tumors.Plitidepsin (Aplidin) is a potent inhibitor of diffuse large cell and Burkitt lymphoma and is synergistic with rituximabNew drugs from the sea.Bioactive peptides and depsipeptides with anticancer potential: sources from marine animalsEffect of Aplidin in acute lymphoblastic leukaemia cells.Didemnins, tamandarins and related natural products.Antiangiogenic activity of aplidine, a new agent of marine originEstablishment and characterisation of a human carcinoma cell line with acquired resistance to Aplidin.Antitumour and antiangiogenic effects of Aplidin in the 5TMM syngeneic models of multiple myelomaAplidine, a new anticancer agent of marine origin, inhibits vascular endothelial growth factor (VEGF) secretion and blocks VEGF-VEGFR-1 (flt-1) autocrine loop in human leukemia cells MOLT-4.Heparin and suramin alter plitidepsin uptake via inhibition of GPCR coupled signaling.In vitro cytotoxicity of aplidin and crossresistance with other cytotoxic drugs in childhood leukemic and normal bone marrow and blood samples: a rational basis for clinical development.Oxidation and inactivation of low molecular weight protein tyrosine phosphatase by the anticancer drug Aplidin.Development of a liquid chromatography/tandem mass spectrometry assay for the quantification of Aplidin, a novel marine-derived antineoplastic agent, in human plasma.New Marine Derived Anticancer Therapeutics ─ A Journey from the Sea to Clinical Trials†.New Marine Derived Anticancer Therapeutics ─ A Journey from the Sea to Clinical Trials
P2860
Q25254985-14858556-2352-4223-8A6D-26C7212010FDQ33980259-594269D1-D120-43FA-9C92-47030B1424AAQ35911656-AFB3C9A9-7F08-4266-94D3-EAEAE3EF70EDQ36028697-44C1DE7B-C4DB-41DD-9B83-D4F800A9032FQ36096750-CD762C84-17FB-454B-B1AA-37609B2B95D6Q36648269-27321F04-E4EB-40D4-AA17-D0464D056369Q37978122-757A9E48-08D1-43F1-8ECE-2FE48FEEAD24Q38796073-79AD5853-24E4-4937-83D8-E114B074368DQ38801730-59AE2525-A157-4E4E-86EF-9A40367293A4Q39638460-568C490B-D001-4436-AAD2-09B3DAF0A19EQ40677359-4A0AFCEC-1BFB-400A-8F42-185FFA398EC5Q43236883-724EB008-A3C6-4318-8BBD-974ABDDFC0D4Q44497842-60130A94-DD11-4E27-948B-D1D820CA3CF7Q46803216-7AF96721-4CD3-48AE-A958-4144E8A475B8Q52953212-8F0E6F0B-BC01-42E3-9529-4AA99D938799Q55712396-C1DC5A80-57F8-4305-91A7-42D9927EEFEAQ56864609-E03211DF-DD0E-40F7-82E7-852908036B4B
P2860
Cell cycle phase perturbations and apoptosis in tumour cells induced by aplidine.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh
2002年學術文章
@zh-hant
name
Cell cycle phase perturbations and apoptosis in tumour cells induced by aplidine.
@en
type
label
Cell cycle phase perturbations and apoptosis in tumour cells induced by aplidine.
@en
prefLabel
Cell cycle phase perturbations and apoptosis in tumour cells induced by aplidine.
@en
P2093
P2860
P356
P1476
Cell cycle phase perturbations and apoptosis in tumour cells induced by aplidine.
@en
P2093
Chiorino G
Codegoni A
D'Incalci M
Desiderio MA
Di Liberti G
Faircloth G
Muradore I
P2860
P2888
P304
P356
10.1038/SJ.BJC.6600265
P407
P577
2002-05-01T00:00:00Z
P5875
P6179
1016868966